University of Central Lancashire research to cut brain cancer diagnosis times

NEW research from The University of Central Lancashire promises to cut brain cancer diagnosis times from two to three days to just 30 minutes.

The research, developed by Dr Matthew Baker and Mr Peter Abel, is based on using a non-invasive technique to diagnose brain cancer by analysing patients’ blood samples using a combination of infrared lighting and protein biomarkers.

Published today on the front cover of the November edition of Analytical and Bioanalytical Chemistry, the revolutionary technique is currently undergoing a patent application.

This method would transform the diagnosis of patients with brain tumours who currently have to wait two to three days in hospital while invasive and uncomfortable tests are carried out on them before they get their results.

More than 16,000 people globally each year are diagnosed with a brain tumour. In the UK, more children and adults under 40 die of a brain tumour than from any other cancer – but despite this, brain tumours receive less than one per cent of the national spend on cancer research.

The research, the result of collaboration between UCLan’s School of Forensic and Investigative Sciences and its School of Pharmacy and Biomedical Sciences, is based on an initial analysis of blood samples donated by 49 cancer patients and 25 non- cancer patients.


Comments are closed on this article.


About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree